Literature DB >> 11972026

A dynamic shift of VEGF isoforms with a transient and selective progesterone-induced expression of VEGF189 regulates angiogenesis and vascular permeability in human uterus.

Magali Ancelin1, Hélène Buteau-Lozano, Geri Meduri, Mary Osborne-Pellegrin, Sylvie Sordello, Jean Plouët, Martine Perrot-Applanat.   

Abstract

A key mechanism underlying physiological angiogenesis of the human endometrium is its ability to regenerate the vascular capillary network and to perform vascular remodeling (i.e., development of spiral arteries). Vascular endothelial growth factor (VEGF) is associated with angiogenesis and capillary permeability in this tissue. VEGF is expressed as several spliced variants, its main human isoforms contain 121 and 165 aa; 17beta-estradiol (E(2)) increases endometrial VEGF, possibly in all isoforms. Here we show that progesterone (P) selectively increases the expression of the VEGF(189) (V(189)) isoform in the human uterus. V(189) is identified in the conditioned medium of stromal cells treated with E(2) + P; its presence in this in vitro model of decidual stromal cells is detected after 6-8 days, using ELISA, and after 8-10 days, using Western blot analysis with different antibodies, including one specific for V(189). The secretion pattern of V(189) parallels that of the decidual protein IGFBP-1. V(189) is secreted as a native isoform, as compared with the migration of recombinant V(189) by SDS/PAGE. In situ hybridization and immunocytochemistry(,) performed on the same biopsies, suggest that decidual cells express V(189) during the mid-late secretory phase of the menstrual cycle and early gestation. Finally, using an in vivo permeability assay, we show that native V(189) increases capillary permeability. These observations demonstrate that P regulates V(189) expression in decidual cells, which could have important implications for understanding uterine vascular remodeling and implantation, and may be relevant in a range of disease states such as edema and irregular bleeding.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11972026      PMCID: PMC122895          DOI: 10.1073/pnas.082110999

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

1.  Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptors alpha and beta.

Authors:  M D Mueller; J L Vigne; A Minchenko; D I Lebovic; D C Leitman; R N Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

2.  Expression of vascular endothelial growth factor receptors in the human endometrium: modulation during the menstrual cycle.

Authors:  G Meduri; P Bausero; M Perrot-Applanat
Journal:  Biol Reprod       Date:  2000-02       Impact factor: 4.285

3.  An immunohistochemical study of human endometrial extracellular matrix during the menstrual cycle and first trimester of pregnancy.

Authors:  J D Aplin; A K Charlton; S Ayad
Journal:  Cell Tissue Res       Date:  1988-07       Impact factor: 5.249

4.  Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis.

Authors:  J L Shifren; J F Tseng; C J Zaloudek; I P Ryan; Y G Meng; N Ferrara; R B Jaffe; R N Taylor
Journal:  J Clin Endocrinol Metab       Date:  1996-08       Impact factor: 5.958

5.  The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules.

Authors:  H Gitay-Goren; S Soker; I Vlodavsky; G Neufeld
Journal:  J Biol Chem       Date:  1992-03-25       Impact factor: 5.157

6.  Paracrine action of vascular endothelial growth factor in the human endometrium: production and target sites, and hormonal regulation.

Authors:  P Bausero; F Cavaillé; G Méduri; S Freitas; M Perrot-Applanat
Journal:  Angiogenesis       Date:  1998       Impact factor: 9.596

7.  High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis.

Authors:  B Millauer; S Wizigmann-Voos; H Schnürch; R Martinez; N P Møller; W Risau; A Ullrich
Journal:  Cell       Date:  1993-03-26       Impact factor: 41.582

8.  Induction of tissue inhibitor of metalloproteinase 3 gene expression during in vitro decidualization of human endometrial stromal cells.

Authors:  T Higuchi; H Kanzaki; H Nakayama; M Fujimoto; H Hatayama; K Kojima; M Iwai; T Mori; J Fujita
Journal:  Endocrinology       Date:  1995-11       Impact factor: 4.736

9.  Progesterone stimulates degradation of urokinase plasminogen activator (u-PA) in endometrial stromal cells by increasing its inhibitor and surface expression of the u-PA receptor.

Authors:  B Casslén; J Nordengren; B Gustavsson; M Nilbert; L R Lund
Journal:  J Clin Endocrinol Metab       Date:  1995-09       Impact factor: 5.958

10.  The isolation and long-term culture of normal human endometrial epithelium and stroma. Expression of mRNAs for angiogenic polypeptides basally and on oestrogen and progesterone challenges.

Authors:  L Zhang; M C Rees; R Bicknell
Journal:  J Cell Sci       Date:  1995-01       Impact factor: 5.285

View more
  24 in total

Review 1.  Dioxin may promote inflammation-related development of endometriosis.

Authors:  Kaylon L Bruner-Tran; Grant R Yeaman; Marta A Crispens; Toshio M Igarashi; Kevin G Osteen
Journal:  Fertil Steril       Date:  2008-04-18       Impact factor: 7.329

2.  Antagonistic functions of tetradecanoyl phorbol acetate-inducible-sequence 11b and HuR in the hormonal regulation of vascular endothelial growth factor messenger ribonucleic acid stability by adrenocorticotropin.

Authors:  Nadia Cherradi; Cyrille Lejczak; Agnes Desroches-Castan; Jean-Jacques Feige
Journal:  Mol Endocrinol       Date:  2005-11-23

3.  Roles of progesterone receptor A and B isoforms during human endometrial decidualization.

Authors:  Hatice S Kaya; Alison M Hantak; Lisa J Stubbs; Robert N Taylor; Indrani C Bagchi; Milan K Bagchi
Journal:  Mol Endocrinol       Date:  2015-04-15

4.  Metabolism of cholesterol and progesterone is differentially regulated in primary trophoblastic subtypes and might be disturbed in recurrent miscarriages.

Authors:  Sigrid Vondra; Victoria Kunihs; Tanja Eberhart; Karin Eigner; Raimund Bauer; Peter Haslinger; Sandra Haider; Karin Windsperger; Günter Klambauer; Birgit Schütz; Mario Mikula; Xiaowei Zhu; Alexander E Urban; Roberta L Hannibal; Julie Baker; Martin Knöfler; Herbert Stangl; Jürgen Pollheimer; Clemens Röhrl
Journal:  J Lipid Res       Date:  2019-09-17       Impact factor: 5.922

Review 5.  Extracellular regulation of VEGF: isoforms, proteolysis, and vascular patterning.

Authors:  Prakash Vempati; Aleksander S Popel; Feilim Mac Gabhann
Journal:  Cytokine Growth Factor Rev       Date:  2013-11-27       Impact factor: 7.638

Review 6.  Autocrine functions of VEGF in breast tumor cells: adhesion, survival, migration and invasion.

Authors:  Martine Perrot-Applanat; Melanie Di Benedetto
Journal:  Cell Adh Migr       Date:  2012-11-01       Impact factor: 3.405

7.  Aberrant endometrial features of pregnancy in diabetic NOD mice.

Authors:  Suzanne D Burke; Hongmei Dong; Aleah D Hazan; B Anne Croy
Journal:  Diabetes       Date:  2007-09-07       Impact factor: 9.461

8.  Overexpression of vascular endothelial growth factor 189 in breast cancer cells leads to delayed tumor uptake with dilated intratumoral vessels.

Authors:  Marie-Astrid Hervé; Hélène Buteau-Lozano; Roger Vassy; Ivan Bieche; Guillaume Velasco; Marika Pla; Gérard Perret; Samia Mourah; Martine Perrot-Applanat
Journal:  Am J Pathol       Date:  2007-12-13       Impact factor: 4.307

Review 9.  Progesterone-Regulated Endometrial Factors Controlling Implantation.

Authors:  Arpita S Bhurke; Indrani C Bagchi; Milan K Bagchi
Journal:  Am J Reprod Immunol       Date:  2016-01-24       Impact factor: 3.886

10.  Retinoic acid is a cofactor for translational regulation of vascular endothelial growth factor in human endometrial stromal cells.

Authors:  Neil Sidell; Yue Feng; Lijuan Hao; Juanjuan Wu; Jie Yu; Maureen A Kane; Joseph L Napoli; Robert N Taylor
Journal:  Mol Endocrinol       Date:  2009-11-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.